全文获取类型
收费全文 | 42071篇 |
免费 | 2462篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 406篇 |
儿科学 | 1290篇 |
妇产科学 | 897篇 |
基础医学 | 6582篇 |
口腔科学 | 415篇 |
临床医学 | 3749篇 |
内科学 | 9851篇 |
皮肤病学 | 994篇 |
神经病学 | 4183篇 |
特种医学 | 1273篇 |
外国民族医学 | 31篇 |
外科学 | 5077篇 |
综合类 | 101篇 |
一般理论 | 8篇 |
预防医学 | 2972篇 |
眼科学 | 680篇 |
药学 | 2877篇 |
中国医学 | 71篇 |
肿瘤学 | 3150篇 |
出版年
2023年 | 241篇 |
2022年 | 161篇 |
2021年 | 629篇 |
2020年 | 408篇 |
2019年 | 716篇 |
2018年 | 1184篇 |
2017年 | 845篇 |
2016年 | 846篇 |
2015年 | 1035篇 |
2014年 | 1104篇 |
2013年 | 1670篇 |
2012年 | 2900篇 |
2011年 | 2873篇 |
2010年 | 1433篇 |
2009年 | 1183篇 |
2008年 | 2645篇 |
2007年 | 2685篇 |
2006年 | 2526篇 |
2005年 | 2573篇 |
2004年 | 2548篇 |
2003年 | 2302篇 |
2002年 | 2233篇 |
2001年 | 1086篇 |
2000年 | 1155篇 |
1999年 | 940篇 |
1998年 | 218篇 |
1997年 | 163篇 |
1996年 | 157篇 |
1995年 | 154篇 |
1994年 | 138篇 |
1993年 | 113篇 |
1992年 | 545篇 |
1991年 | 479篇 |
1990年 | 469篇 |
1989年 | 435篇 |
1988年 | 393篇 |
1987年 | 383篇 |
1986年 | 354篇 |
1985年 | 325篇 |
1984年 | 233篇 |
1983年 | 184篇 |
1982年 | 110篇 |
1979年 | 163篇 |
1974年 | 124篇 |
1973年 | 108篇 |
1972年 | 111篇 |
1971年 | 119篇 |
1970年 | 107篇 |
1969年 | 131篇 |
1968年 | 112篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
Marion Tardieu Najat Salameh Line Souris David Rousseau Laurène Jourdain Hanadi Skeif François Prévot Ludovic de Rochefort Denis Ducreux Bruno Louis Philippe Garteiser Ralph Sinkus Luc Darrasse Marie Poirier-Quinot Xavier Maître 《NMR in biomedicine》2022,35(7):e4701
Magnetic resonance elastography aims to non-invasively and remotely characterize the mechanical properties of living tissues. To quantitatively and regionally map the shear viscoelastic moduli in vivo, the technique must achieve proper mechanical excitation throughout the targeted tissues. Although it is straightforward, ante manibus, in close organs such as the liver or the breast, which practitioners clinically palpate already, it is somewhat fortunately highly challenging to trick the natural protective barriers of remote organs such as the brain. So far, mechanical waves have been induced in the latter by shaking the surrounding cranial bones. Here, the skull was circumvented by guiding pressure waves inside the subject's buccal cavity so mechanical waves could propagate from within through the brainstem up to the brain. Repeatable, reproducible and robust displacement fields were recorded in phantoms and in vivo by magnetic resonance elastography with guided pressure waves such that quantitative mechanical outcomes were extracted in the human brain. 相似文献
2.
3.
4.
Balázs Nemes Réka P. Szabó Dávid Péntek Ildikó Nagy Gergely Ivády Bettina Kárai Eszter Szánthó Zsuzsa Hevessy Sándor Sipka Gergő J. Szőllősi Sándor Baráth 《Transplantation proceedings》2021,53(5):1423-1432
IntroductionThe usage of extended-criteria donors (ECD) became a routinely accepted manner in the last decade. ECD is a potential risk factor for antibody-mediated rejection. Analysis of lymphocyte subsets might be a complementary diagnostic toolkit because there is limited knowledge about this term.MethodBetween May 12, 2016, and September 4, 2019, a total of 130 patients who had undergone kidney transplant were investigated. Patients were divided in ECD and standard criteria donor (SCD) groups. Blood samples were collected before the operation, then in the first week and after 30, 60, 180, and 365 days. Besides routine laboratory tests, multicolor flow cytometry was performed for lymphocyte subsets.ResultsECD grafts were transplanted to older recipients. The number of CD4+ cells increased in the SCDs from the first week to until the end of first month, and then decreased. The number of CD4+ cells decreased from the beginning of the study until the end of first year to 66% of its original value in ECDs. At the first month, the number of CD19+ cells was higher in SCD compared with ECD cases; the number then decreased in both groups. T-regulatory cells had a drop at the first week that lasted until the first month. A bigger increase in SCD and a moderate increase in ECD group were then observed. The kinetics of CD19+ and CD19+ naive cells are similar in the ECD and SCD groups. In the SCD group, cell count decreased in both CD19+ (13%) and CD19+ naive (12%) between third and sixth month. The count of CD19+ cells decreased by 9%, but the count of CD19+ naive cells increased by 11% between the sixth month and first year.DiscussionThe prolonged postoperative uremic state caused by the poorer initial function, together with an aging immune system, explains the weaker immune response in ECD patients, which may be the cause of the decreased number of memory and regulatory T cells. Older patients with an ECD graft need a tailored, personalized, and less aggressive immunosuppressive treatment. 相似文献
5.
Florian Huemer Thomas Melchardt Bettina Jansko Adam Wahida Stefanie Jilg Philipp J. Jost Eckhard Klieser Katja Steiger Teresa Magnes Lisa Pleyer Sigrun Greil‐Ressler Christof Rass Richard Greil Alexander Egle 《European journal of haematology》2019,102(5):437-441
Acute myeloid leukemia (AML) is a disease of the elderly population and survival remains poor after failure of hypomethylating agents (HMA). The BCL‐2 inhibitor venetoclax demonstrated activity as monotherapy and in combination with chemotherapy or HMA in AML. In this case series, patients with secondary AML (sAML) not eligible for intensive chemotherapy and refractory to HMA were treated with venetoclax within a named patient program at our tertiary cancer center in Salzburg, Austria. Between April 2017 and September 2018, seven patients with sAML received venetoclax therapy. Two out of seven patients achieved a complete remission upon venetoclax initiation with a PFS of 505 days and 352 days and another patient achieved complete peripheral blood blast clearing within nine days after start of venetoclax. Among the venetoclax responders, primary refractory disease to prior HMA therapy was documented, 2 patients harbored IDH1/IDH2 mutations and one patient had an antecedent myeloproliferative neoplasm. High BCL‐2 and/or BIM expression in myeloblasts was found in venetoclax responders and response was significantly associated with overall survival (responders: 364 days versus non‐responders: 24 days, P = 0.018). Venetoclax monotherapy is safe and is able to induce durable responses in elderly patients with secondary AML after treatment failure with HMA. 相似文献
6.
7.
8.
Andrea Garatti Andrea Daprati Marzia Cottini Claudio F. Russo Margherita Dalla Tomba Giovanni Troise Antonio Salsano Francesco Santini Roberto Scrofani Francesca Nicolò Elisa Mikus Alberto Albertini Luca Di Marco Davide Pacini Marco Picichè Loris Salvador Guglielmo M. Actis Dato Paolo Centofanti Lorenzo Menicanti 《The Annals of thoracic surgery》2021,111(4):1242-1251
9.
Valérie Delisle Jean Perron Valérie Lafrenière-Bessi Jean-Marc Côté Christian Drolet Christian Couture Frédéric Jacques 《The Canadian journal of cardiology》2019,35(4):544.e3-544.e5
Cardiac hemangioma is rare, even more when leading to a cardiovascular collapse in a seemingly healthy newborn. A 6-day-old neonate had a tamponade caused by a basolateral hemangioma of the left ventricle. Partial surgical resection was performed. A congenital lobular capillary hemangioma was diagnosed upon histologic examination. The patient recovered completely and shows normal development at the 12-month follow-up. 相似文献
10.
E. Albrecht D. Capel J. B. Rossel M. R. Wolmarans A. Godenèche D. De Paulis J. Cabaton 《Anaesthesia》2023,78(3):315-319
Prolongation of peripheral nerve blockade by intravenous dexamethasone may be extended by intravenous dexmedetomidine. We randomly allocated 122 participants who had intravenous dexamethasone 0.15 mg.kg−1 before interscalene brachial plexus block for day-case arthroscopic rotator cuff repair to intravenous saline (62 participants) or intravenous dexmedetomidine 1 μg.kg−1 (60 participants). The primary outcome was time from block to first oral morphine intake during the first 48 postoperative hours. Fifty-nine participants reported taking oral morphine, 25/62 after placebo and 34/60 after dexmedetomidine, p = 0.10. The time to morphine intake was shorter after dexmedetomidine, hazard ratio (95%CI) 1.68 (1.00–2.82), p = 0.049. Median (IQR [range]) morphine doses were 0 (0–12.5 [0–50]) mg after control vs. 10 (0–30 [0–50]) after dexmedetomidine, a difference (95%CI) of 7 (0–10) mg, p = 0.056. There was no effect of dexmedetomidine on pain at rest or on movement. Intra-operative hypotension was recorded for 27/62 and 50/60 participants after placebo vs. dexmedetomidine, respectively, p < 0.001. Other outcomes were similar, including durations of sensory and motor block. In conclusion, dexmedetomidine shortened the time to oral morphine consumption after interscalene block combined with dexamethasone and caused intra-operative hypotension. 相似文献